Abstract
ABSTRACT Surveillance strategies in differentiated thyroid cancers (DTCs) differ from other head-and-neck subsites by virtue of their excellent prognosis. Guidelines in this chapter are based on a comprehensive literature review, particularly in the Indian setting concurred upon by experts in the field. Key recommendations include serial measurement of thyroglobulin values, thyroglobulin antibodies, and risk-based suppression of thyroid-stimulating hormone during follow-up of treated DTCs, with radioactive iodine scan and structural imaging based on dynamic risk stratification. These recommendations take into consideration prevailing Indian scenario related to reliability of follow-up, insurance coverage, as well as burden on health-care systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Head & Neck Physicians and Surgeons
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.